A new phase of trials to test two promising HIV vaccines began last week in London and Oxford. The vaccines—one made of naked DNA, the other a weakened pox virus—contain genes from a common strain of HIV in Africa, and should provoke an immune response that fends off the virus itself. Volunteers are receiving different combinations of the vaccines or a placebo. Teams at Imperial College in London and the Medical Research Council’s Human Immunology Unit in Oxford hope to recruit 120 volunteers aged 18 to 60, who must be HIV-negative.
To continue reading, today with our introductory offers
Advertisement
More from Â鶹´«Ă˝
Explore the latest news, articles and features
Popular articles
Trending Â鶹´«Ă˝ articles
1
Autism may have two distinct subtypes that vary by brain activity
2
A quantum state that lasts forever may finally be within our grasp
3
The secrets to keeping your brain sharp in old age
4
Sperm have been made magnetic to allow IVF inside the body
5
Fully autonomous drones have killed human soldiers for the first time
6
Has the answer to life's origins been hiding in our cells all along?
7
Arctic Ocean reaches tipping point that could be dire for marine life
8
Walking shark found in Papua New Guinea is new to science
9
Understanding anorexia’s grip on the brain could unlock new therapies
10
What if the idea of the autism spectrum is completely wrong?
